NIH-funded research R21 grant

Improving molecular tests for congenital syphilis

Official title: Pre-Analytic Factors affecting Molecular tests for Congenital Syphilis

Funded at Ut Southwestern Medical Center · NIH-11173804 · Data updated 2026-11-12

Checking how the way samples are collected and handled affects a new molecular test that aims to directly detect syphilis in pregnant people and newborns.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startAugust 20, 2024
Project endJuly 31, 2026
Funding year2025
Award (this year)$205,000
NIH project number5R21AI185968-02
Project IDNIH-11173804 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are pregnant people with suspected or confirmed syphilis and newborns or infants born to mothers with syphilis or uncertain treatment history.

Less likely to help

People without exposure to syphilis or adults with long-established syphilis diagnoses are unlikely to gain direct benefit from this diagnostic-methods work.

What this research studies

This work looks at how pre-test factors—like the type of sample (blood, amniotic fluid, or newborn swabs), how long samples sit before testing, and how they are stored—change the accuracy of a PCR-based test for Treponema pallidum. Researchers will run molecular tests on different kinds of specimens and compare results after varying collection and handling conditions to find what gives the most reliable detection. The project focuses on samples from pregnant people, newborns, and early infants to target congenital syphilis. Findings will inform how hospitals and labs should collect and transport samples so a direct test could work better in real-world care.

Why it matters

Potential benefit: If successful, this could lead to a reliable direct test that helps doctors detect syphilis in babies earlier and make clearer treatment decisions.

How similar studies have gone: PCR-based detection of T. pallidum has worked in some sample types, but prior results have been inconsistent and no routine molecular newborn test has been established.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Sorelle, Jeffrey — Ut Southwestern Medical Center
  • Study coordinator: Sorelle, Jeffrey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.